Saluda Medical Announces New 3-Month, 12-Month and 18-Month Da... - 20 May 2019 18:00

ARTARMON, Australia, May 20, 2019 /PRNewswire-AsiaNet/ -- --11 Presentations - Including 4 Plenary Presentations - to Feature the Evoke System Saluda Medical Pty Limited ("Saluda Medical") today announced that new data from multiple studies evaluating the company's Evoke(R) ECAP-Controlled, Closed-Lo...

  Kazia Enters Clinical Collaboration for Metastatic Brain Cance... - 20 May 2019 14:29

SYDNEY, May 20, 2019 /PRNewswire-AsiaNet/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into a collaboration with the Alliance for Clinical Trials in Oncology Foundation (Alliance), a U...

  A New Approach to Treating Alzheimer's Disease Receives Major ... - 20 May 2019 14:01

RESEARCH TRIANGLE PARK, North Carolina, May 20, 2019 /PRNewswire-AsiaNet/ -- - T3D Therapeutics to Receive $9 Million Multiyear National Institute on Aging Grant for Phase 2 PIONEER Study in Mild-to-Moderate Alzheimer's Disease Patients T3D Therapeutics, a clinical stage drug development company engaged in the developme...

  Inovio and QIAGEN Establish Collaboration to Develop Diagnosti... - 17 May 2019 06:11

PLYMOUTH MEETING, Pa., GERMANTOWN, Md., HILDEN, Germany, May 17, 2019 /PRNewswire-AsiaNet/ --Liquid biopsy-based Precision Medicine test to guide patient selection for Inovio's VGX-3100 Inovio Pharmaceuticals Inc. (NASDAQ: INO) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration to co-develop ...

  Merck Data at ASCO 2019 Showcase Multiple Innovative Molecules... - 16 May 2019 09:12

DARMSTADT, Germany, May 16, 2019, /PRNewswire-AsiaNet/-- Not intended for UK- , Canada- or US-based media ASCO Abstract # Bintrafusp alfa (bifunctional fusion protein): TPS9114; Tepotinib (MET kinase inhibitor): 9005; Discovery: 2567; ERBITUX(R) (cetuximab): 3580; BAVENCIO(R) (avelumab): 9569; 101;...

  Apollo Proton Cancer Centre, Chennai Performs India’s First To... - 16 May 2019 01:06

CHENNAI, India, May 15, 2019, /PRNewswire-AsiaNet/ -- In a first-ever milestone in cancer treatment in India, the Apollo Proton Cancer Center (APCC) in Chennai has successfully performed Total Marrow Irradiation (TMI) as a conditioning protocol prior to Bone Marrow Transplant. Logo: https...

  Collinson Continues Medical Assistance Expansion With Aspen Me... - 16 May 2019 00:37

LONDON, May 15, 2019 /PRNewswire-AsiaNet/ -- Fully comprehensive assistance service for complex international deployment Collinson, an expert in global traveller assistance, has further enhanced its medical assistance capability through a partnership with Aspen Medical, an Australian-own...

  Hangzhou attracts RMB1.5 billion investments in bio-pharmaceut... - 15 May 2019 23:42

HANGZHOU, China, May 15, 2019 /PRNewswire-AsiaNet/ -- Hangzhou, capital of east China's Zhejiang Province, has seen seven bio-pharmaceutical projects implemented in the first quarter of the year, with a total investment of 1.5 billion yuan, according to the latest data of the Hangzhou Investment Prom...

  Inovio and Plumbline Life Sciences Establish Animal Health Col... - 15 May 2019 23:00

PLYMOUTH MEETING, Pa. and SEOUL, South Korea, May 15, 2019 /PRNewswire-AsiaNet/ -- Inovio Pharmaceuticals Inc. (NASDAQ: INO) and Plumbline Life Sciences (XKRX: 222670) today announced a collaboration to co-develop a novel animal health vaccine for African swine fever (ASF) virus. The vaccine will be developed using Inovio's SynC...

  Pneuma Respiratory and Leads Biolabs, Inc. Announce Partnership - 15 May 2019 10:16

BOONE, North Carolina, May 15, 2019 /PRNewswire-AsiaNet/ -- Pneuma Respiratory, Inc., developer of a proprietary breath-activated digital inhaler (BDI), and Leads Biolabs Inc. announce an agreement granting Pneuma an exclusive license to develop Leads Biolabs' panel of immuno-oncology monoclonal antibodies...